The Delhi High Court has issued a temporary restraining order against Patanjali Ayurved, preventing the company from airing television commercials that allegedly disparage Dabur India's Chyawanprash. Justice Mini Pushkarna granted Dabur's request for an interim injunction, citing concerns over Patanjali's claims regarding superior knowledge and a higher number of herbs in their product. The court has scheduled the next hearing for July 14.

Dabur India initiated legal action against Patanjali, contending that the Ramdev-led firm was running a defamatory advertising campaign against its Chyawanprash. Dabur sought an injunction against these commercials, which they claimed were designed to malign their brand. Dabur had initially filed two interim injunction applications in the suit in December of last year, during which summons were issued.

Dabur argued that despite the court's earlier directives, Patanjali broadcast as many as 6,182 commercials within a single week, allegedly targeting Dabur's product. This was presented as part of Dabur's second application for injunction. Senior Advocate Sandeep Sethi, representing Dabur, told the court that Patanjali had falsely advertised their Chyawanprash as containing over 51 herbs, when it allegedly only contained 47. He also raised concerns that Patanjali's product contained mercury, making it potentially unsafe for children.

Dabur also objected to Patanjali's description of Dabur's Chyawanprash, which contains around 40 herbs, as "ordinary". Dabur argued that this implied that only Patanjali's formulation adhered to Ayurvedic principles, casting doubt on the legitimacy of Dabur's product and deliberately disparaging it. Dabur representatives stated that Patanjali's ads attempted to undermine their legacy and connection to Ayurvedic traditions, misrepresenting Patanjali's own ingredient composition, attacking Dabur's association with Ayurvedic heritage, and characterizing Dabur's product as inferior.

Dabur currently holds a 61.6% market share in the Chyawanprash segment. Dabur also referenced prior contempt proceedings against Patanjali in the Supreme Court over similar advertising tactics, alleging a pattern of repeated violations.

Countering Dabur's allegations, Senior Advocate Jayant Mehta, representing Patanjali, rejected all claims made by Dabur. He asserted that the ingredients in Patanjali's Chyawanprash fully complied with approved Ayurvedic formulations and that the product was safe for consumption.